Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a common hormone problem quietly harm your brain?

NCT ID NCT07304674

Recruiting now Knowledge-focused Sponsor: Xinjiang Medical University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 1,000 adults with primary aldosteronism—a condition where the adrenal glands make too much aldosterone—to see how it affects thinking and memory over up to 5 years. Participants will take regular cognitive tests and have medical check-ups. The goal is to learn how often cognitive decline happens and what factors might influence it.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could reveal how often cognitive problems occur in people with primary aldosteronism and what factors increase risk, pointing toward ways to protect brain health.
What could go wrong
This is an observational study, not a treatment trial, so it cannot prove cause and effect. Results may take years and might not lead to direct changes in care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COGNITIVE DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cognitive disorder Cognitive Dysfunction dementia hyperaldosteronism primary aldosteronism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COGNITIVE DYSFUNCTION DEMENTIA MILD COGNITIVE IMPAIRMENT (MCI) PRIMARY ALDOSTERONISM

Contacts and locations

Locations

  • The First Affiliated Hospital of Chengdu Medical College

    RECRUITING

    Chengdu, Sichuan, 610000, China

  • The First Affiliated Hospital of Xinjiang Medical University

    RECRUITING

    Ürümqi, Xinjiang, 830000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.